Carteriosulfonic acids A-C, GSK-3beta inhibitors from a Carteriospongia sp.
about
Kinase inhibitors from marine spongesBioactive marine drugs and marine biomaterials for brain diseasesModulation of Wnt/β-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer.Recent progress in neuroactive marine natural products.Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisSecondary Metabolites from the Marine Sponge Genus Phyllospongia.
P2860
Carteriosulfonic acids A-C, GSK-3beta inhibitors from a Carteriospongia sp.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Carteriosulfonic acids A-C, GSK-3beta inhibitors from a Carteriospongia sp.
@ast
Carteriosulfonic acids A-C, GSK-3beta inhibitors from a Carteriospongia sp.
@en
type
label
Carteriosulfonic acids A-C, GSK-3beta inhibitors from a Carteriospongia sp.
@ast
Carteriosulfonic acids A-C, GSK-3beta inhibitors from a Carteriospongia sp.
@en
prefLabel
Carteriosulfonic acids A-C, GSK-3beta inhibitors from a Carteriospongia sp.
@ast
Carteriosulfonic acids A-C, GSK-3beta inhibitors from a Carteriospongia sp.
@en
P2093
P2860
P50
P356
P1476
Carteriosulfonic acids A-C, GSK-3beta inhibitors from a Carteriospongia sp.
@en
P2093
Chris M Ireland
Gina C Mangalindan
Gisela P Concepcion
Malcolm W B McCulloch
Mary Kay Harper
Misha M Mutizwa
Tim S Bugni
P2860
P304
P356
10.1021/NP900336F
P577
2009-09-01T00:00:00Z